Yahoo
OTC Markets OTCPK - Delayed Quote USD

Biora Therapeutics, Inc. (BIORQ)

0.0001 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
892
4
305
1,247
Cost of Revenue
--
--
--
0
Gross Profit
--
--
--
1,247
Operating Expense
61,765
67,147
62,086
119,084
Operating Income
-60,873
-67,143
-61,781
-117,837
Net Non Operating Interest Income Expense
-7,324
-9,815
-10,990
-12,636
Other Income Expense
32,465
-47,466
23,521
-48,167
Pretax Income
-35,732
-124,424
-49,250
-178,640
Tax Provision
-158
-90
-420
-119
Net Income Common Stockholders
-31,539
-124,115
-38,157
-247,412
Diluted NI Available to Com Stockholders
-31,539
-124,115
-38,157
-247,412
Total Operating Income as Reported
-60,873
-67,143
-61,781
-117,837
Total Expenses
61,765
67,147
62,086
119,084
Net Income from Continuing & Discontinued Operation
-31,539
-124,115
-38,157
-247,412
Normalized Income
-83,273.1468
-142,324.9771
-69,555.7324
-124,400.0764
Interest Expense
7,324
9,815
10,990
12,636
Net Interest Income
-7,324
-9,815
-10,990
-12,636
EBIT
-28,408
-114,609
-38,260
-166,004
EBITDA
-27,965
-114,054
-37,353
-164,567
Reconciled Cost of Revenue
--
--
--
0
Reconciled Depreciation
443
555
907
1,437
Net Income from Continuing Operation Net Minority Interest
-35,574
-124,334
-48,830
-178,521
Total Unusual Items Excluding Goodwill
47,911
18,004
20,904
-54,157
Total Unusual Items
47,911
18,004
20,904
-54,157
Normalized EBITDA
-75,876
-132,058
-58,257
-110,410
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
211.8532
13.0229
178.2676
-36.0764
12/31/2021 - 6/19/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: